Skip to main content
. 2011 Feb 28;16(4):512–522. doi: 10.1634/theoncologist.2010-0174

Figure 1.

Figure 1.

Epithelioid sarcoma (ES) and unclassified sarcoma with epithelioid features (USEF) outcome analysis. Kaplan–Meier disease-specific survival curves stratified for patients with localized versus metastatic ES (p < .0001) (A), patients with localized distal ES versus localized proximal ES (p = .03) (B), patients with ES versus USEF (p = .22) (C), patients with localized versus metastatic USEF (p = .05) (D), and patients with localized ES versus localized USEF (p = .09) (E).